Canine immune-mediated hemolytic anemia: treatment and prognosis.
The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.
Balch
Andrea
A
Las Vegas Veterinary Referral Center, USA.
Mackin
Andrew
A
D000367:Age Factors; D000744:Anemia, Hemolytic, Autoimmune / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D000818:Animals; D001803:Blood Transfusion / Q000662:veterinary*; D004283:Dog Diseases / Q000473:pathology* / Q000628:therapy*; D004285:Dogs; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D013156:Splenectomy / Q000662:veterinary*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents